Articles From: Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference to Chemtura Reports Third Quarter 2014 Financial Results


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m. (ET) at the Crowne Plaza Hotel in New York City.
Sign-up for Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference investment picks
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2014, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5.1% to $358 million GAAP Diluted EPS increased 47.9% to $1.39 Adjusted Diluted EPS increased 8.8% to $1.48 VITAS segment operating results: Net Patient Revenue of $265 million, an increase of 4.5% Average Daily Census (ADC) of 14,639, an increase of 2.8% Admissions of 15,653,
Sign-up for Chemed Reports Third-Quarter 2014 Results investment picks
MIDLAND, Mich., Nov.
Sign-up for Chemical Financial Corporation Announces Fourth Quarter Cash Dividend investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Announces Third Quarter 2014 Earnings Conference Call investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Completes Acquisition of Northwestern Bancorp, Inc. investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Reports 2014 Third Quarter Operating Results investment picks
Enhances preeminent Michigan-based retail banking franchise with addition of leading, entrepreneurial, relationship-oriented commercial bank Adds approximately $1.2 billion in assets, $1.0 billion in deposits, and $0.9 billion in loans Augments Michigan's largest branch network outside of the Detroit MSA with additional locations in high-growth MSAs Results in estimated 10% EPS accretion in first full year MIDLAND, Mich.
Sign-up for Chemical Financial Corporation to Partner With Lake Michigan Financial Corporation investment picks
MIDLAND, Mich., Nov.
Sign-up for Chemical Financial Corporation to Partner With Monarch Community Bancorp, Inc. investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168476&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Chemmart Pharmacy Extends Innovative, Personalized Customer Experience to the Web With Oracle Commerce investment picks
Primary Endpoint Achieved; Statistically Significant Reduction in Urinary Protein Over 52 Weeks MOUNTAIN VIEW, Calif., Dec.
Sign-up for ChemoCentryx Announces Positive Results in Phase II Diabetic Nephropathy Trial With CCR2 Inhibitor CCX140 investment picks
SHIELD 4 Efficacy Results in Line With Positive Results in PROTECT-1, an Earlier Phase II Clinical Trial in Crohn's Disease MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease investment picks
MOUNTAIN VIEW, Calif., Nov.
Sign-up for ChemoCentryx Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx to Hold Third Quarter 2014 Financial Results Conference Call on Wednesday, November 5, 2014 investment picks
MOUNTAIN VIEW, Calif., Jan.
Sign-up for ChemoCentryx to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
MOUNTAIN VIEW, Calif., Nov.
Sign-up for ChemoCentryx to Present at Two Upcoming Investor Conferences investment picks
In Vivo Data Also Show Synergistic Effect of Combination Therapy With CCX507 and Approved Anti-Integrin Antibody in Colitis Model MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx's Orally Administered CCR9 Inhibitor, CCX507, Shown to be Well Tolerated and Effective in CCR9 Blockade in Phase I Study investment picks
2015/1/21
Chemtrade Logistics Income Fund Declares January Distribution Canada NewsWire TORONTO , Jan.
Sign-up for Chemtrade Logistics Income Fund Declares January Distribution investment picks
PHILADELPHIA, Dec.
Sign-up for Chemtura Announces Final Results of Tender Offer investment picks
PHILADELPHIA, Dec.
Sign-up for Chemtura Announces Preliminary Results of Tender Offer investment picks
PHILADELPHIA, Oct.
Sign-up for Chemtura Corp. Postpones Investor Day to Feb. 5, 2015 investment picks
Third Quarter 2014 GAAP net earnings from continuing operations of $0.17 per diluted share and net earnings from continuing operations of $0.20 per diluted share on a managed basis PHILADELPHIA, Oct.
Sign-up for Chemtura Reports Third Quarter 2014 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference to Chemtura Reports Third Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent